Eudaimonia Partners’s Marvell Technology MRVL Stock Holding History

Eudaimonia Partners’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-116	Closed	-$6K	–	986
2021 Q1	$6K	Buy	+116	New	+$5.68K	﹤0.01%	1289

Other funds holding MRVL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Eudaimonia Partners's MRVL Position: Q2 2021 in Review

Eudaimonia Partners sold out of Marvell Technology (MRVL) in Q2 2021, closing a stake of 116 shares — an estimated $6K sold.

Eudaimonia Partners first reported a position in MRVL in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 742 funds tracked by Wall St. Rank hold MRVL as of Q2 2021.

Eudaimonia Partners reported no remaining Marvell Technology position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 116 Marvell Technology shares in Q2 2021, an estimated $6K.
Eudaimonia Partners first reported a position in Marvell Technology in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Marvell Technology position peaked at $6K in Q1 2021.
742 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.